As the ticks that spread Lyme disease push ever further into Canada, doctors are starting to notice an unusual fallout from the growing threat: a spike in the number of people seeking help for arthritis triggered by the bacteria.
Friday, April 4, 2014 - 10:57
Friday, April 4, 2014 - 10:53
Almost immediately following FDA approval for Otezla in psoriatic arthritis, Celgene posted trial data supporting its case for the broader psoriasis population. Patients receiving Otezla for 52 weeks demonstrated a mean psoriasis area and... + read more
Friday, April 4, 2014 - 10:50
Perrigo Company, a leading global healthcare supplier, has initiated market launch and made its first shipments of the authorised generic version of LEO Pharma A/S' Taclonex ointment (calcipotriene 0.005per cent/betamethasone dipropionate... + read more
Tuesday, April 1, 2014 - 16:11
Results of two late-stage clinical trials showed high efficacy for Novartis' drug secukinumab when used by patients suffering from moderate-to-severe plaque psoriasis, the Swiss drugmaker said on Saturday. The results of the Phase III... + read more